The pursuit of groundbreaking innovation in advanced therapeutic medicinal products (ATMPs) is a high-stakes endeavor, particularly for early-stage biotech startups…
Read More
Excalipoint Therapeutics Launches with $68.7 Million Seed Funding to Advance Novel T-Cell Engager Pipeline
Chinese biotech startup Excalipoint Therapeutics has officially launched with a substantial $68.7 million in seed funding, positioning itself to accelerate…
Read More
Meningitis B Vaccine Expansion Under Consideration Amidst Kent Outbreak
The United Kingdom’s Health Secretary, Wes Streeting, is reportedly considering expanding the national immunisation schedule to include the Meningitis B…
Read More
The World Health Organization Targets Urgent Antibiotic Development to Combat Evolving Drug Resistance
The World Health Organization (WHO) has taken a significant step in its ongoing battle against antimicrobial resistance (AMR) by publishing…
Read More
